Market Overview

The Market In 5 Minutes: Retail Earnings Come Into Focus

The Market In 5 Minutes: Retail Earnings Come Into Focus
Benzinga's Daily Biotech Pulse: AbbVie Launches New Pediatric Humira, IPO Deluge Hits The Street
10 Biggest Price Target Changes For Monday
AbbVie's Humira could face pressure from biosimilars, analyst says (Seeking Alpha)
Related CALM
Mid-Morning Market Update: Markets Mixed; International Speedway Posts Mixed Q1 Results
Mid-Afternoon Market Update: Dow Falls Over 500 Points; Crude Oil Down 2.5%

Macro Focus

Futures for the Dow Jones Industrial Average climbed 91 points to 18,623.00, while the Standard & Poor’s 500 index futures gained 9 points to 2,169.25. Futures for the Nasdaq 100 index surged 30.50 points to 4,851.00.

Oil prices traded lower as Brent crude futures fell 0.19 percent to trade at $46.27 per barrel, while US WTI crude futures also fell 0.91 percent to trade at $44.86 a barrel.

Initial Jobless Claims for Nov 4 254.0K vs 260.0K estimate. Prior reading was 265.0K. Continuing Claims for Oct 28 2.04M vs 2.03M estimate.

  • St. Louis Federal Reserve Bank President James Bullard is set to speak in St. Louis, Mo. at 9:15 a.m. ET.
  • The Energy Information Administration’s weekly report on natural gas stocks is schedule for release at 10:30 a.m. ET.
  • The Treasury budget data for October is schedule for release at 2:00 p.m. ET.
  • Data on money supply for the recent week will be released at 4:30 p.m. ET.

BZ News Desk Focus

  • Macy's (NYSE: M) Reports Q3 Adj. EPS $0.17, Sales $5.63B vs $5.65B Est.
  • Kohl's (NYSE: KSS) Reports Q3 Adj. EPS $0.80 vs $0.70 Est., Sales $4.327B vs $4.33B Est.
  • Taser (NASDAQ: TASR) Reports Q3 EPS $0.07 vs. Est. $0.06, Sales $71.9M vs $59M Est.
  • Mylan (NASDAQ: MYL) Reports Q3 EPS $1.38 vs. Est. $1.46, Rev. $3.06B vs. Est. $3.12B
  • Shake Shack (NYSE: SHAK) Reports Q3 Adj EPS $0.15 vs $0.14 Est, Revenue $74.6M vs $69.33M, Comps Up $2.9%

Sell-Side Themes

Barclays upgraded a few defensive names. Lockheed Martin (NYSE: LMT) got an Equal-Weight rating and $275 target, while Northrup Grumman (NYSE: NOC) got bumped to Overweight with a $270 target. L-3 Communications (NYSE: L) was upgraded to Overweight with a $165 target.

Sell-Side's Most Noteworthy Calls

  • Rodman & Renshaw downgraded Valeant (NYSE: VRX) to Neutral.
  • Morgan Stanely downgraded Qualcomm (NASDAQ: QCOM) to Equal-Weight.
  • Bank of America upgraded IBM (NYSE: IBM) to Buy.
  • JPMorgan upgraded Humana (NYSE: HUM) to Overweight.
  • Goldman Sachs started Cal-Maine Foods (NASDAQ: CALM) at Neutral.

Deal Talk

Merrimack Pharmaceuticals (NASDAQ: MACK) is said to be working with Credit Suisse and Bank of America on a strategic review that could lead to a sale of assets or a licensing deal, according to sources as reported by Reuters on Wednesday. AbbVie (NYSE: ABBV) and Pfizer (NYSE: PFE) might have an interest in the company's cancer drugs, the sources said.

Investors in MDC Partners (NASDAQ: MDCA) are breathing a sigh of relief following news the company reached an agreement in principle to settle a probe with the SEC. Albert Fried's Rich Tullo has urged the company to merge with a big player like Publicis. He sees the timeline for such a deal before the second quarter of 2017.

Ron Burkle and Sam Nazarian’s SBE Entertainment were close to seeing the window close on their ability to complete their buyout of the Morgans Hotel Group. Morgans is running out of cash and needs to find a buyer/financing by year end.

In The News

Over the last couple of weeks, Carl Icahn has taken “buying the dip” to the extreme. With that idea in mind and his most recent 13F filing as a guide, traders can look for other Icahn favorites that he could be looking to buy next.

Donald Trump’s stunning presidential victory shook the political establishment to its core and sent shock waves through global markets. Wall Street Journal broke it down hour-by-hour.


This Reddit thread is freaking out about the Trump win: "Seriously guys, buy now for stupidly cheap and wait for the markets to eventually rise. Don't sell, that's stupid you'll lose all potential profit."



Thousands across the country protested in major cities following Donald Trump's Presidential election win. #TrumpProtest

Guess This Chart

  • This company reported on Thursday Q3 Adj. EPS $0.80 vs $0.70 Est., Sales $4.327B vs $4.33B Est. Also comps were down 1.7% in Q3.
  • In July, this company was rumored to have obtained financing for a "going private" deal, at the same time they cancelled out of a conference.
  • Sympathy plays include Sears, JC Penney and Macy's

Posted-In: Market in 5 minutesNews Global Top Stories Pre-Market Outlook Markets Best of Benzinga


Related Articles (CALM + ABBV)

View Comments and Join the Discussion!